Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Finasteride and analogues separated using LC-MS-MS technique.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Androgens increase EPO production, finasteride doesn't significantly impact it.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Finasteride use can cause lasting negative effects like sexual dysfunction, depression, anxiety, and cognitive issues.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Hirsutism causes significant psychological distress in women.

Finasteride doesn't affect antipyrine metabolism, so interactions with cytochrome P-450 enzyme drugs are unlikely.

Early diagnosis and treatment, like topical minoxidil, can prevent hair loss in children.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

Using rodents for research shows that health problems in the womb can cause diseases later in life.